UBS Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
UBS Group's MEDP Position: Q3 2026 in Review
UBS Group reduced its Medpace (MEDP) stake by 62% in Q3 2026, selling an estimated $110M and leaving 116,114 shares worth $72.5M. The position accounts for 0.01% of the portfolio, ranked #1350.
UBS Group first reported a position in MEDP in Q3 2016 and has held it in 41 quarters since. The position peaked at $185M in Q4 2025. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.
- UBS Group held 116,114 shares of Medpace worth $72.5M as of Q3 2026.
- UBS Group sold 187,812 Medpace shares in Q3 2026, an estimated $110M.
- Medpace made up 0.01% of UBS Group's portfolio in Q3 2026, its #1350 holding.
- UBS Group first reported a position in Medpace in Q3 2016 and has held it in 41 quarters since.
- UBS Group's Medpace position peaked at $185M in Q4 2025.
- 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.